Metabolic implications of amino acid metabolites in chronic kidney disease progression: a metabolomics analysis using OPLS-DA and MBRole2.0 database
- 20 September 2023
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 56 (3) , 1173-1184
Abstract
Background As chronic kidney disease (CKD) progresses, metabolites undergo diverse transformations. Nevertheless, the impact of these metabolic changes on the etiology, progression, and prognosis of CKD remains uncertain. Our objective is to conduct a metabolomics analysis to scrutinize metabolites and identify significant metabolic pathways implicated in CKD progression, thereby pinpointing potential therapeutic targets for CKD management. Methods We recruited 145 patients with CKD and determined their mGFR by measuring the plasma iohexol clearance, whereupon we partitioned them into four groups based on their mGFR values. Non-targeted metabolomics analysis was conducted using UPLC-MS/MS assays. Differential metabolites were identified via one-way ANOVA, PCA, PLS-DA, and OPLS-DA analyses employing the MetaboAnalyst 5.0 platform. Ultimately, we performed differential metabolite pathway enrichment analysis, using both the MetaboAnalyst 5.0 platform and the MBRole2.0 database. Results According to the findings of the MBRole2.0 and MetaboAnalyst 5.0 enrichment analysis, six amino acid metabolism pathways were discovered to have significant roles in the progression of CKD, with the glycine, serine, and threonine metabolism pathway being the most prominent. The latter enriched 14 differential metabolites, of which six decreased while two increased concomitantly with renal function deterioration. Conclusions The metabolic analysis unveiled that glycine, serine, and threonine metabolism plays a pivotal role in the progression of CKD. Specifically, glycine was found to increase while serine decreased with the deterioration of CKD.Keywords
Funding Information
- the Science and Technology Development Fund, Macau SAR (File no. 0032/2018/A1)
- The National Natural Science Foundation of China (Grant No. 81873631, 81370866, 81070612)
- the Guangzhou Science and Technology Planning Project (Grant No. 202002020047)
This publication has 39 references indexed in Scilit:
- Role of the Gut Microbiome in Uremia: A Potential Therapeutic TargetAmerican Journal of Kidney Diseases, 2016
- Effect of Insulin Sensitizer Therapy on Amino Acids and Their MetabolitesMetabolism, 2015
- Plasma Metabolomic Profiles in Different Stages of CKDClinical Journal of the American Society of Nephrology, 2013
- Human serum metabolic profiles are age dependentAging Cell, 2012
- Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease PatientsClinical Journal of the American Society of Nephrology, 2009
- N-acetyltransferase 8, a positional candidate for blood pressure and renal regulation: resequencing, association and in silico studyBMC Medical Genetics, 2008
- Renal injury due to renin–angiotensin–aldosterone system activation of the transforming growth factor-β pathwayKidney International, 2006
- Total Synthesis of Mannosyl Tryptophan and Its DerivativesChemistry – A European Journal, 2003
- Amino acid metabolism in uremia.Journal of the American College of Nutrition, 1989
- beta-Hydroxyasparagine in domains homologous to the epidermal growth factor precursor in vitamin K-dependent protein S.Proceedings of the National Academy of Sciences, 1987